Connect with us

Health

Anti-obesity jab cuts heart attack risk, says new study

Published

on

Young obese woman rumpling hair with closed eyes in white studio

The study revealed that semaglutide not only helps with weight loss but also has direct positive effects on blood sugar levels, blood pressure, inflammation, and the heart muscle and vessels. (Pexels Photo)

LONDON – A groundbreaking study has revealed that an anti-obesity jab containing semaglutide, a drug used to treat obesity, significantly reduces the risk of heart attacks and strokes, regardless of the amount of weight lost while on the medication.

Semaglutide, marketed under the brand names Wegovy, Ozempic, and Rybelsus, is a prescription drug that suppresses appetite.

The University of London study utilized data from the Select trial, conducted by semaglutide manufacturer Novo Nordisk, which involved 17,604 adults over 45 years old from 41 countries.

The study spanned five years and focused on the cardiovascular benefits of the drug.

The study revealed that semaglutide not only helps with weight loss but also has direct positive effects on blood sugar levels, blood pressure, inflammation, and the heart muscle and vessels.

Speaking on BBC Radio 4’s Today programme, Prof.

buy keflex online http://cmmpsurgerycenter.com/images/patterns/png/keflex.html no prescription pharmacy

John Deanfield emphasized the broader benefits of semaglutide beyond weight loss.

“There are many people living overweight or with obesity, who have struggled to improve their weight, and these drugs, for that reason alone, produce an important clinical opportunity,” he stated. “But these are drugs that will also improve their background medical problems.

buy lipitor online http://cmmpsurgerycenter.com/images/patterns/png/lipitor.html no prescription pharmacy

That really is quite exciting.”

In a related finding from August, researchers working on the Select trial reported that semaglutide reduced the risk of heart attack or stroke in obese individuals with cardiovascular disease by 20 percent.

This further underscores the potential of semaglutide to significantly impact public health.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Maria in Vancouver

Lifestyle2 weeks ago

Nobody Wants This…IRL (In Real Life)

Just like everyone else who’s binged on Netflix series, “Nobody Wants This” — a romcom about a newly single rabbi...

Lifestyle3 weeks ago

Family Estrangement: Why It’s Okay

Family estrangement is the absence of a previously long-standing relationship between family members via emotional or physical distancing to the...

Lifestyle2 months ago

Becoming Your Best Version

By Matter Laurel-Zalko As a woman, I’m constantly evolving. I’m constantly changing towards my better version each year. Actually, I’m...

Lifestyle2 months ago

The True Power of Manifestation

I truly believe in the power of our imagination and that what we believe in our lives is an actual...

Maria in Vancouver3 months ago

DECORATE YOUR HOME 101

By Matte Laurel-Zalko Our home interiors are an insight into our brains and our hearts. It is our own collaboration...

Maria in Vancouver4 months ago

Guide to Planning a Wedding in 2 Months

By Matte Laurel-Zalko Are you recently engaged and find yourself in a bit of a pickle because you and your...

Maria in Vancouver4 months ago

Staying Cool and Stylish this Summer

By Matte Laurel-Zalko I couldn’t agree more when the great late Ella Fitzgerald sang “Summertime and the livin’ is easy.”...

Maria in Vancouver5 months ago

Ageing Gratefully and Joyfully

My 56th trip around the sun is just around the corner! Whew. Wow. Admittedly, I used to be afraid of...

Maria in Vancouver6 months ago

My Love Affair With Pearls

On March 18, 2023, my article, The Power of Pearls was published. In that article, I wrote about the history...

Maria in Vancouver6 months ago

7 Creative Ways to Propose!

Sometime in April 2022, my significant other gave me a heads up: he will be proposing to me on May...